Exagen Inc. ( XGN) - Key Metrics
XGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.77 | -$0.22 | -$0.14 | -$0.14 |
| 2025Q3 | $0.75 | -$0.31 | $0.13 | $0.12 |
| 2025Q2 | $0.82 | -$0.21 | -$0.14 | -$0.15 |
| 2025Q1 | $0.84 | -$0.20 | -$0.58 | -$0.58 |
XGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -7.01 |
| 2025Q3 | ? | -8.86 |
| 2025Q2 | ? | -8.29 |
| 2025Q1 | ? | -4.44 |
XGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -14.87% | ? |
| 2025Q4 | -2.33% | ? |
| 2025Q3 | 1.06% | ? |
| 2025Q2 | -2.10% | ? |
| 2025Q1 | -16.19% | ? |
XGN
Price: $4.68
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 10300
Market Capitalization: 87.9 million